These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36737216)

  • 21. Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer.
    Zhang B; Liu Q; Liu M; Shi P; Zhu L; Zhang L; Li R
    J Biomater Appl; 2019 May; 33(10):1382-1393. PubMed ID: 30880565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-Sensitive ZnO Quantum Dots-Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery.
    Cai X; Luo Y; Zhang W; Du D; Lin Y
    ACS Appl Mater Interfaces; 2016 Aug; 8(34):22442-50. PubMed ID: 27463610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-responsive targeting drug delivery system for combination photothermal/chemotherapy of tumor.
    Yang Y; Wu S; Zhang Q; Chen Z; Wang C; Jiang S; Zhang Y
    J Biomater Sci Polym Ed; 2023 Feb; 34(2):166-183. PubMed ID: 35943449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy.
    Fang J; Zhang S; Xue X; Zhu X; Song S; Wang B; Jiang L; Qin M; Liang H; Gao L
    Int J Nanomedicine; 2018; 13():5113-5126. PubMed ID: 30233175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redox/pH dual stimuli-responsive ZnO QDs-gated mesoporous silica nanoparticles as carriers in cancer therapy.
    Wang W; Wang Y; Wang Y; Gong H; Zhu H; Liu M
    IET Nanobiotechnol; 2019 Aug; 13(6):640-649. PubMed ID: 31432799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging.
    Zhao Q; Wang S; Yang Y; Li X; Di D; Zhang C; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():475-484. PubMed ID: 28576012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Int J Biol Macromol; 2018 May; 111():1106-1115. PubMed ID: 29357289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabrication of autofluorescent porous silica nanoparticles for redox-responsive drug release.
    Cao N; Zhao Y; Sang B; Wang Z; Cao L; Sun L; Zou X
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():330-6. PubMed ID: 27612720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
    Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of pH-responsive long-circulating polysaccharide-drug conjugate nanocarriers for antitumor applications.
    Zhang X; Li D; Huang J; Ou K; Yan B; Shi F; Zhang J; Zhang J; Pang J; Kang Y; Wu J
    J Mater Chem B; 2019 Jan; 7(2):251-264. PubMed ID: 32254550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cationic Conjugated Polymer/Hyaluronan-Doxorubicin Complex for Sensitive Fluorescence Detection of Hyaluronidase and Tumor-Targeting Drug Delivery and Imaging.
    Huang Y; Song C; Li H; Zhang R; Jiang R; Liu X; Zhang G; Fan Q; Wang L; Huang W
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21529-37. PubMed ID: 26331442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.